Guideline Updated for Use of Radiation for Brain Metastases
The updated guideline reviews advanced radiation therapy techniques and places emphasis on multidisciplinary care.
Breast Cancer News
BREAST CANCER ADVISOR
Breast Cancer News
Infertility Linked to Increased Risk of Breast Cancer in Men
Researchers found a significant increase in the risk of breast cancer among men who had not fathered any children.
Etirinotecan Pegol Provides No OS Benefit in Breast Cancer With Brain Metastases
The findings contradict results from the phase 3 BEACON study.
AYA Cancer Survivors Twice As Likely to Die From Second Cancer
The risk of dying from a subsequent primary cancer remained significantly elevated for 20 years or more for some patients.
Digital Breast Tomosynthesis Tool Can Help Predict Breast Cancer
A DBT-based risk model can predict cancer after a negative screening exam, with high discriminative performance for one-year risk.
HER2-Low Should Not Be a Distinct Subtype of Breast Cancer, Researchers Say
There were no significant differences in outcomes between patients with low HER2 expression and those with no HER2 expression, after adjusting for hormone receptor status.
Ceralasertib Provides No Benefit in Advanced Triple-Negative Breast Cancer
Combining ceralasertib with olaparib did not improve response rates or progression-free survival.
Combination Produces Longest Survival to Date in Treatment-Naïve Advanced Breast Cancer
Adding ribociclib to fulvestrant prolonged overall survival by 15.8 months.
Patritumab Deruxtecan Yields Responses in HR+/HER2- Breast Cancer
Patritumab deruxtecan produced “clinically meaningful” responses, according to researchers.
Breast Cancer Guidelines May Be Supported by Low-Quality Reviews
Nearly half of the systematic reviews supporting 5 guidelines were of “critically low” quality.
Trials Supporting Cancer Drug Approvals Lack Information on Gender
Of more than 100 studies used to support drug approvals, none reported information on the gender of participants.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Cancer Researchers Aren’t Reporting Quality of Life Outcomes Accurately
Quality of life outcomes were reported favorably for trials that showed no improvement in quality of life.
Enhertu Approval Broadens Breast Cancer Indication to Earlier Use
The approval was based on data from the phase 3 DESTINY-Breast03 trial.
Proton Beam Therapy Increasingly Used to Treat Cancers, Even When Evidence of Effectiveness Is Lacking
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
Recurrent DCIS Not Always Related to Primary Tumor
Researchers found that, in 18% of recurrences, the new tumor was molecularly unrelated to the original tumor.
Having MS May Impact Cancer Screening, Diagnosis
Multiple sclerosis was associated with reduced odds of screen-detected breast cancer.
Eponyms in Oncology: Li-Fraumeni Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
Consider COVID Vax History When Assessing Adenopathy on Mammo
Axillary lymphadenopathy persisted up to 43 weeks after COVID-19 vaccination.
NAFLD Associated With Long-Term Risk for Extrahepatic Cancers
Researchers investigated the association between NAFLD and the risk of extrahepatic cancers.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Breast Cancer News
Loading... 
Loading...